Macrophage Pharma Limited

Trending Articles

  1. Scleroderma treatment by Certa Therapeutics granted US FDA fast track FT011 is a novel, first-in-class oral therapy for the treatment of chronic fibrosis in multiple organs
  2. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  3. Indian government bans three medicines owing to health risks Decision follows strong stand on suspending marketing of all drugs prohibited for sale in other countries, including the US, UK, EU and Australia
  4. Dickson achieves ISO 14001 certification ISO 14001 certification highlights a companies' long-term efforts to manage its environmental impact
  5. The key role of IVDs in healthcare: challenges to commercialisation and access In simple terms, in vitro diagnostic (IVD) tests are done on samples such as blood or tissue that have been taken from the human body. IVDs can detect diseases, conditions and...

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Research & Development

Macrophage Pharma appoints scientific advisory board

Macrophage Pharma appoints Dr Michael Moore as Chairman
Media

Immuno-oncology CRO secures Macrophage Pharma agreement

Aquila BioMedical, an innovative preclinical contract research organisation (CRO) now part of Concept Life Sciences group, has secured an extended agreement with UK-based biotech firm Macrophage Pharma to support its preclinical immuno-oncology programmes

Macrophage Pharma appoints Development Director

Joanne Bedwell-Garner joins management team
Finance

Macrophage Pharma raises £9 million in Series A financing and acquires immune-oncology technology platform

Macrophage Pharma Limited, a newly formed immune-oncology company, has announced that it has successfully raised £9 million in a Series A equity financing round.
Subscribe now